FDA Drug Recalls

Recalls / Class II

Class IID-1020-2019

Product

Phenylephrine HCl, 500 mcg in 0.9% Sodium Chloride, QS 5 mL Injectable Solution 500 mcg/5 mL (100 mcg per mL), 5mL Sterile single use syringe, NDC: 42852-830-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404

Affected lot / code info
Lots: 01/18/19 3261 83067S Exp. 6/17/2019; 10/18/18 0212 83067S Exp. 3/17/2019; 10/23/18 7704 83067S Exp. 3/22/2019; 11/02/18 5909 83067S Exp. 4/1/2019; 10/31/18 8995 83067S Exp. 3/30/2019; 10/22/18 2570 83067S Exp. 3/21/2019; 10/18/18 6471 83067S Exp. 3/17/2019; 11/05/18 5527 83067S Exp. 4/4/2019; 11/05/18 0985 83067S Exp. 4/4/2019; 10/22/18 9234 83067S Exp. 3/21/2019; 10/30/18 6678 83067S Exp. 3/29/2019

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Advanced Pharma Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
9265 Kirby Dr, N/A, Houston, Texas 77054-2520

Distribution

Quantity
16075 syringes
Distribution pattern
Nationwide

Timeline

Recall initiated
2019-03-13
FDA classified
2019-03-21
Posted by FDA
2019-03-27
Terminated
2020-01-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1020-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls